CASE REPORT |
|
Year : 2018 | Volume
: 66
| Issue : 5 | Page : 697-699 |
|
Bilateral herpes simplex keratitis reactivation after lacrimal gland botulinum toxin injection
Purvasha Narang1, Swati Singh2, Vikas Mittal1
1 Cornea Services, LJ Eye Institute, Ambala, Haryana, India 2 Oculoplasty Services, LJ Eye Institute, Ambala, Haryana, India
Correspondence Address:
Dr. Vikas Mittal LJ Eye Institute, Ambala - 134 003, Haryana India
Source of Support: None, Conflict of Interest: None | Check |
DOI: 10.4103/ijo.IJO_904_17
|
|
Botulinum toxin A (BTA) injections into lacrimal gland are being used for refractory epiphora due to intractable lacrimal disorders with success rates reported from 18% to 86%. Most common side effects are transient ptosis and diplopia. We report a case of a 59-year-old female injected with 2.5 units of BTA injection in each lacrimal gland for functional epiphora. The patient had a history of herpes simplex viral keratitis that was quiescent for more than 2 years. After 3 weeks, she developed reactivation of viral keratitis bilaterally, which was successfully managed with antivirals and topical steroids. Reactivation of quiescent herpes simplex keratitis is a possibility after lacrimal gland BTA and caution should be exercised in such cases.
|
|
|
|
[FULL TEXT] [PDF]* |
|
|
|